Core Laboratories (CLB) Projected to Post Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) will likely be posting its quarterly earnings results after the market closes on Wednesday, April 23rd. Analysts expect Core Laboratories to post earnings of $0.15 per share and revenue of $125.09 million for the quarter. Core Laboratories has set its Q1 2025 guidance at 0.120-0.160 EPS.Parties interested in registering for the company’s conference call can do so using this link.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Performance

NYSE CLB opened at $11.99 on Wednesday. The company has a market capitalization of $559.86 million, a PE ratio of 18.16, a P/E/G ratio of 0.99 and a beta of 1.99. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. Core Laboratories has a 1 year low of $10.14 and a 1 year high of $25.13. The company has a fifty day moving average of $14.81 and a two-hundred day moving average of $17.57.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date was Monday, February 10th. Core Laboratories’s dividend payout ratio is currently 6.06%.

Analyst Upgrades and Downgrades

CLB has been the topic of a number of recent research reports. Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and lifted their target price for the company from $15.00 to $16.00 in a report on Wednesday, March 12th. Stifel Nicolaus dropped their price objective on shares of Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a research note on Tuesday. One research analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $15.75.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.